Quantum Biopharma (QNTM) Share-based Compensation (2019 - 2026)
Quantum Biopharma (QNTM) reported Share-based Compensation of $892057.0 for Q1 2026, up 206.26% on a YoY basis from $291272.0 in Q1 2025, and up 10.34% sequentially from $808452.0 in Q4 2025.
Quantum Biopharma (QNTM) Share-based Compensation (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 8 years of Share-based Compensation data on file, last reported at $892057.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 206.26% year-over-year to $892057.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 819.34% YoY), and the FY2025 full-year result was $2.9 million, up 1835.11% from the prior year.
- Share-based Compensation advanced to $892057.0 in Q1 2026, from $808452.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.2 million in Q1 2023 to a low of -$82477.0 in Q4 2024.
- A 5-year average of $550382.7 and a median of $355006.0 in 2022 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 3755.82% in 2023 and plunged 182.99% in 2024, its largest moves.
- Tracing QNTM's Share-based Compensation over 5 years: stood at $506583.0 in 2022, then plunged by 80.38% to $99384.0 in 2023, then sank by 182.99% to -$82477.0 in 2024, then soared by 1080.22% to $808452.0 in 2025, then rose by 10.34% to $892057.0 in 2026.
- Business Quant data shows QNTM's Share-based Compensation at $892057.0 in Q1 2026, $808452.0 in Q4 2025, and $996194.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.20 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9.26 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 87.30 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 892,057.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 892,057.00 |
| Mar 31, 2026 | 892,057.00 |
| Dec 31, 2025 | 808,452.00 |
| Dec 31, 2025 | 808,452.00 |
| Sep 30, 2025 | 996,194.00 |
| Sep 30, 2025 | 996,194.00 |
| Jun 30, 2025 | 849,584.00 |
| Jun 30, 2025 | 849,584.00 |
| Mar 31, 2025 | 291,272.00 |
| Mar 31, 2025 | 291,272.00 |
| Dec 31, 2024 | -82,477.00 |
| Dec 31, 2024 | -82,477.00 |
| Sep 30, 2024 | 65,424.00 |
| Sep 30, 2024 | 65,424.00 |
| Jun 30, 2024 | 111,524.00 |
| Jun 30, 2024 | 111,524.00 |
| Mar 31, 2024 | 57,743.00 |
| Mar 31, 2024 | 57,743.00 |
| Dec 31, 2023 | 99,384.00 |
| Dec 31, 2023 | 99,384.00 |